Search results
Added:
3 years ago
The incidence of AF is on the rise.1–3 This is secondary not only to increasing prevalence but also a focus on increased recognition of occult AF for primary thromboembolic (TE) prevention.4 How we identify and treat these patients with AF is constantly in flux. While it is possible that a novel procedure or antiarrhythmic drug could create sweeping changes in AF management overnight, here we…
View more
Added:
3 years ago
Atrial fibrillation (AF) is the most common pathologic clinical arrhythmia lasting more than 30 seconds, and its incidence and prevalence continue to increase. It has been estimated that 5.9 % of patients aged >65 years suffer from AF.1 In the Rotterdam study, 17.8 % of patients over 85 had AF.2 The lifetime risk for developing AF in both men and women above age 40 is one in four.3 This…
View more
Added:
3 years ago
Dyspnea, palpitations, edema, and fatigue are common symptoms during pregnancy. For women with congenital heart disease (CHD), it may be difficult to discern whether symptoms are due to normal pregnancy or underlying cardiac disease. Although most women with CHD tend to experience successful pregnancies, morbidity and mortality are significantly increased with more complex CHD lesions.1–6 Women…
View more
The Impact of Haemorrhagic Complications on Mortality in Acute Coronary Syndromes—Implications for…
Added:
3 years ago
Article
Added:
3 years ago
In July 2004, the American College of Cardiology (ACC) and the American Heart Association (AHA) Joint Task Force on Practice Guidelines released new practice guidelines for ST-elevation myocardial infarction (STEMI), which emphasize the need for speed when chest pain or other symptoms of a heart attack strike. Speedy treatment not only means the difference between life and death but also between…
View more
Added:
3 years ago
In July 2004, the American College of Cardiology (ACC) and the American Heart Association (AHA) Joint Task Force on Practice Guidelines released new practice guidelines for ST-elevation myocardial infarction (STEMI), which emphasize the need for speed when chest pain or other symptoms of a heart attack strike. Speedy treatment not only means the difference between life and death but also between…
View more
Added:
2 years ago
Added:
1 year ago
AHA 22 - Principal investigator of the PRECISE Trial (NCT03702244), Dr Pamela Douglas (Duke University School of Medicine, US) joins Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) to discuss the trial design and the new data presented at the Scientific Sessions.
The rationale of the PRECISE trial was to evaluate if a precision approach of coronary-CTA-led diagnostic pathways…
View more
Added:
2 years ago
ACS in the Elderly
Added:
1 year ago
Article
« First